Brief: Alliqua Biomedical announces CEO David Johnson's 2014 compensation
27/03/2015 13:07
March 27 (Reuters) - Alliqua BioMedical Inc ALQA.O : * Says CEO David Johnson's FY 2014 total compensation was $3.3 million versus $5.5 million in FY 2013 - SEC filing * Source text for Eikon ID:nEOL7PPb9h * Further company coverage ALQA.O ((Bengaluru Newsroom; +1 646 223 8780))